A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer

Anticancer Research

Volumn 28, Issue 2 A, 2008, Pages 577-581

  Foster, Paul A ^a   Newman, Simon P ^a   Leese, Mathew P ^b   Bernetiere, Sonia ^c   Diolez, Christian ^c   Camara, Jose ^c   Hacher, Beatrice ^d   Baronnet, Marie Madeleine ^d   Ali, Tauhid ^c   Potter, Barry V L ^b   Reed, Michael J ^a   Purohit, Atul ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b University of Bath   (United Kingdom)

^c IPSEN   (France)

^d Dreux Office   (France)

Author keywords

2 methoxyestradiol; Breast cancer; Estrogen; STX140; Sulfamate

Indexed keywords

2 METHOXYESTRADIOL 3,17 O,O BIS SULFAMATE; ESTROGEN DERIVATIVE; METHYLCELLULOSE; PROPYLENE GLYCOL; SODIUM CHLORIDE; STX 140; TETRAHYDROFURAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INOCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; CELL LINE, TUMOR; DOSAGE FORMS; ESTRENES; FEMALE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; RATS; RATS, SPRAGUE-DAWLEY; VISCOSITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 42549154737     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics. CA Cancer J Clin 55: 77-108, 2005.
2. Klauber N, Parangi S, Flynn E, Hamel E and D'Amato RJ: Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57: 81-86, 1997.
3. Dahut WL, Lakhani NJ, Gulley JL, Arlen PM, Kohn EC, Kotz H, McNally D, Parr A, Nquyen D, Yang SX, Steinberg SM, Ventiz, Sparreboom A and Figg WD: Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol Ther 5: 22-27, 2006.
4. Newman SP, Ireson CR, Tutill HJ, Day JM, Parsons MF, Leese MP, Potter BVL, Reed MJ and Purohit A: The role of 17β-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells. Cancer Res 66: 324-330, 2006.
5. Sano T, Hirasawa G, Takeyama J, Darnel AD, Suzuki T, Moriya T,Kato K, Sekine H, Ohara S, Shimoseqawa T, Nakamura J, Yoshihama M, Harada N and Sasano H: 17 beta-hydroxysteroid dehydrogenase type 2 expression and enzyme activity in the human gastrointestinal tract. Clin Sci (Lond) 101: 485-491, 2001.
6. MacCarthy-Morrogh L, Townsend PA, Purohit A, Hejaz HAM, Potter BVL, Reed MJ and Packham G: Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells. Cancer Res 60: 5441-5450, 2000.
7. Raobaikady B, Reed MJ, Leese MP, Potter BVL and Purohit A: Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates. Int J Cancer 117: 150-159, 2005.
8. Foster PA, Ho YT, Newman SP, Kasprzyk PG, Leese MP, Potter BVL, Reed MJ and Purohit A: 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Res Treat, in press, 2007.
9. Newman SP, Leese MP, Purohit A, James DR, Rennie CE, Potter BVL and Reed MJ: Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates. Int J Cancer 109: 533-540, 2004.
10. Purohit A, Hejaz HA, Walden L, MacCarthy-Morrogh L, Packham G, Potter BVL and Reed MJ: The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. Int J Cancer 85: 584-589, 2000.
11. Day JM, Newman SP, Comninos A, Solomon C, Purohit A, Leese MP, Potter BVL and Reed MJ: The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells. J Steroid Biochem Mol Biol 84: 317-325, 2003.
12. Ireson CR, Chander SK, Purohit A, Perera S, Newman SP, Parish D, Leese MP, Smith AC, Potter BVL and Reed MJ: Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 90: 932-937, 2004.
13. Purohit A, Williams GJ, Howarth NM, Potter BVL and Reed MJ: Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry 34: 11508-11514, 1995.
14. Leese MP, Leblond B, Smith A, Newman SP, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ and Potter BVL: 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. J Med Chem 28: 7683-7696, 2006.
15. Hidalgo Aragones MI, Purohit A, Parish D, Sahm UG, Pouton CW, Potter BVL and Reed MJ: Pharmacokinetics of oestrone-3-O-sulphamate. J Steroid Biochem Mol Biol 58: 611-617, 1996.
16. Amaral MH, Lobo JM and Ferreira DC: Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets. AAPS PharmSciTech 2: E6, 2001.